Search all medical codes

Adverse effect of unspecified fibrinolysis-affecting drugs

ICD10CM code

Similar Codes


ICD10CM codes

T45.605 - Adverse effect of unspecified fibrinolysis-affecting drugs
T45.695 - Adverse effect of other fibrinolysis-affecting drugs
T45.605A - Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45.605D - Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
T45.605S - Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
T45.60 - Poisoning by, adverse effect of and underdosing of unspecified fibrinolysis-affecting drugs
T45.606 - Underdosing of unspecified fibrinolysis-affecting drugs
T45.695S - Adverse effect of other fibrinolysis-affecting drugs, sequela
T45.695D - Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
T45.695A - Adverse effect of other fibrinolysis-affecting drugs, initial encounter

HCPCS codes

D9630 - OTHER DRUGS AND/OR MEDICAMENTS
D9610 - THERAPEUTIC PARENTERAL DRUG
G8969 - Documentation of patient reason(s) for not prescribing warfarin or another fda-approved oral anticoa
G8971 - Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given
D9612 - THERAPEUTIC PARENTERAL DRUGS
G9928 - Warfarin or another fda-approved anticoagulant not prescribed, reason not given
G8696 - Antithrombotic therapy prescribed at discharge
G8968 - Documentation of medical reason(s) for not prescribing warfarin or another fda-approved anticoagulan
J3246 - Injection, tirofiban hcl, 0.25 mg
G8935 - Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (

CPT4 codes

85410 - Fibrinolytic factors and inhibitors; alpha-2 antiplasmin
85415 - Fibrinolytic factors and inhibitors; plasminogen activator
85390 - Fibrinolysins or coagulopathy screen, interpretation and report
85420 - Fibrinolytic factors and inhibitors; plasminogen, except antigenic assay
85290 - Clotting; factor XIII (fibrin stabilizing)
85397 - Coagulation and fibrinolysis, functional activity, not otherwise specified (eg, ADAMTS-13), each ana
85300 - Clotting inhibitors or anticoagulants; antithrombin III, activity
85366 - Fibrin(ogen) degradation (split) products (FDP) (FSP); paracoagulation
85305 - Clotting inhibitors or anticoagulants; protein S, total
85705 - Thromboplastin inhibition, tissue